These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3898494)

  • 21. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
    Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo studies of the maintenance of peripheral transplant tolerance after cyclosporine. Radiosensitive antigen-specific suppressor cells mediate lasting graft protection against primed effector cells.
    Nisco SJ; Hissink RJ; Vriens PW; Hoyt EG; Reitz BA; Clayberger C
    Transplantation; 1995 May; 59(10):1444-52. PubMed ID: 7539554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporine: progress, problems, and perspectives.
    Van Buren CT
    Surg Clin North Am; 1986 Jun; 66(3):435-49. PubMed ID: 3520887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of T cytotoxic cells after perioperative treatment with extracted antigen and cyclosporine in rat cardiac transplantation.
    Ito T; Stepkowski S; Kahan BD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1045-52. PubMed ID: 3291214
    [No Abstract]   [Full Text] [Related]  

  • 25. The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts.
    Roelen DL; van Beelen E; van Bree SP; van Rood JJ; Völker-Dieben HJ; Claas FH
    Transplantation; 1995 Apr; 59(7):1039-42. PubMed ID: 7709440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lethal graft-vs-host disease induced by a class II MHC antigen only disparity is not mediated by cytotoxic T cells.
    Thiele DL; Bryde SE; Lipsky PE
    J Immunol; 1988 Nov; 141(10):3377-82. PubMed ID: 3053897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporine and the immune response: basic aspects.
    Hess AD; Colombani PM; Esa AH
    Crit Rev Immunol; 1986; 6(2):123-49. PubMed ID: 2942335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immunobiology of experimental lung transplantation with cyclosporine immunosuppression: cytolytic T lymphocytes and delayed type hypersensitivity in rejecting and tolerant recipients.
    Norin AJ
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):125-30. PubMed ID: 2966476
    [No Abstract]   [Full Text] [Related]  

  • 29. Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT).
    Kedar E; Or R; Naparstek E; Zeira E; Slavin S
    Bone Marrow Transplant; 1988 Mar; 3(2):129-40. PubMed ID: 3048477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens.
    Tykodi SS; Warren EH; Thompson JA; Riddell SR; Childs RW; Otterud BE; Leppert MF; Storb R; Sandmaier BM
    Clin Cancer Res; 2004 Dec; 10(23):7799-811. PubMed ID: 15585611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung transplantation: effect of cyclosporine A on the frequency of cytolytic lymphocytes recovered from blood and the bronchoalveolar space.
    Kirby JA; Reader JA; Pepper JR
    J Heart Transplant; 1986; 5(1):33-8. PubMed ID: 3302156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma.
    Fowler DH; Gress RE
    Leuk Lymphoma; 2000 Jul; 38(3-4):221-34. PubMed ID: 10830730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells.
    Thiele DL; Charley MR; Calomeni JA; Lipsky PE
    J Immunol; 1987 Jan; 138(1):51-7. PubMed ID: 2946780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The importance of the spleen for the immunosuppressive action of cyclosporine in transplantation.
    Meiser BM; Morris RE
    Transplantation; 1991 Mar; 51(3):690-6. PubMed ID: 2006527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of interleukin 2 on the immunosuppressive action of cyclosporine.
    Hess AD
    Transplantation; 1985 Jan; 39(1):62-8. PubMed ID: 3155579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alloreactive T suppressor cells in the rat. I. Evidence of three distinct subsets of splenic suppressor T cells resistant to cyclosporine.
    Rodrigues MA; Hutchinson IV; Morris PJ
    Transplantation; 1989 May; 47(5):847-52. PubMed ID: 2524122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro correlates of in vivo therapy with cyclosporine to immunosuppress rejection of heterotopic rat cardiac allografts across strong (RT-1) plus weak (non-RT-1) histocompatibility differences.
    Miyagawa S; Stepkowski SM; Lawen JG; Rutzky LP; Kahan BD
    Transplantation; 1991 Nov; 52(5):851-7. PubMed ID: 1835196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A potential synergistic effect of donor antigenic extracts and cyclosporine on the prolongation of rat renal allografts.
    Tsuda T; Kahan BD
    Transplantation; 1983 May; 35(5):483-9. PubMed ID: 6342227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.